PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) today announced that the U.S. Food and Drug Administration (FDA) has approved VABOMERE™ (meropenem and vaborbactam) for injection ...

Tango I was a randomised, double-blind, double-dummy trial that compared meropenem with vaborbactam (2 g/2 g IV [intravenous] over 3 hours, every 8 hours) with piperacillin with tazobactam (4 g/0.5 g ...

Discover comprehensive details about Meropenem and Vaborbactam, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated ...

• Meropenem and vaborbactam injection is available as a powder for reconstitution which has to be mixed with 0.9% sodium chloride injection. • Mix the contents of the vial gently and dilute further ...

BETHLEHEM, PA--(Marketwired - Jul 11, 2016) - B. Braun Medical Inc., a leader in infusion therapy and pain management, announced today that it has launched its new 500mg Meropenem for Injection USP ...

The results showed that meropenem/vaborbactam was non-inferior to piperacillin/tazobactam with an overall success rate of 98.4% vs 94.0%. Results from the Phase 3 ...

In a study, IV fosfomycin appeared less effective than IV ceftriaxone or meropenem for bacteremic UTI caused by multidrug-resistant E. coli, but the drug may be considered for selected patients with ...

The use of intravenous antibiotics to treat patients at home requires that the therapy be provided safely and cost-effectively. Ideal agents for home use provide the necessary spectrum of ...

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is ...

The content of this evidence review was up-to-date in November 2019. See summaries of product characteristics (SPCs), British national formulary (BNF), or the Medicines and Healthcare products ...